118 results
Page 3 of 6
8-K
EX-1.1
qam2i 5g688y
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
jjgis
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.1
cscv4
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
ut2kf29hkjt5fg 5wet
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.3
8fq 3dml3j
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
1md gkqs5f
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
j63 afol9y6w0g
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
f9ogo9upgiic 9rexh0s
26 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-1.1
c10roh d90prdre
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
pvs0xsjhwqyxfjyx 2ae
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
he50ft0qn 20plbo
23 Jun 20
Prospectus supplement for primary offering
4:06pm